Physician profile
Jack O Gladstein
NPI 1508870551
$528.04
in general payments reported to CMS, 2019-2025
11 companies · $57.10 in 2025
The $57.10 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $174 · 2024: $23.83 · 2025: $57.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $175.00 | 2019 | |
| Allergan, INC. | $174.38 | 2020 | |
| Promius Pharma LLC | $86.14 | 2019 | |
| Pharming Healthcare, INC. | $23.83 | 2024 | Ruconest |
| Kyowa Kirin, INC. | $20.99 | 2025 | |
| Cmp Pharma, INC. | $19.28 | 2025 | Norliqva, Liqrev, Atorvaliq |
| Neurelis, INC. | $16.83 | 2025 | Valtoco |
| Lilly USA, LLC | $11.59 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Gladstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.